The rationale for the study was anecdotal reports of the effects of breast milk used by mothers to treat blocked tear ducts, ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...

The South Carolina Burn Center at the Medical University of South Carolina and The Zucker Institute for Innovation ...

Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration ...

MediWound , an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase III trial for its treatment for venous leg ulcers.

Years ago, a young patient's mother told Emily McCourt, MD, associate professor of ophthalmology at the University of ...

Birth tissue donation is part of a growing statewide program with thousands of participants run through Tennessee Donor Services.

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

Beyond Stargate's big players, a growing number of innovators have been revolutionizing healthcare by making recent ...

The Cleveland Clinic describes the vital role of a healthy placenta. It's a temporary organ that forms in the uterus, or womb ...